Oxygenta Pharmaceutical (BOM:524636) Days Sales Outstanding : 162.22 (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical Days Sales Outstanding?

Oxygenta Pharmaceutical's average Accounts Receivable for the three months ended in Dec. 2023 was ₹162.7 Mil. Oxygenta Pharmaceutical's Revenue for the three months ended in Dec. 2023 was ₹91.5 Mil. Hence, Oxygenta Pharmaceutical's Days Sales Outstanding for the three months ended in Dec. 2023 was 162.22.

The historical rank and industry rank for Oxygenta Pharmaceutical's Days Sales Outstanding or its related term are showing as below:

BOM:524636' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.13 Med: 25.13 Max: 95.61
Current: 95.61

During the past 12 years, Oxygenta Pharmaceutical's highest Days Sales Outstanding was 95.61. The lowest was 7.13. And the median was 25.13.

BOM:524636's Days Sales Outstanding is ranked worse than
71.04% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.845 vs BOM:524636: 95.61

Oxygenta Pharmaceutical's Days Sales Outstanding increased from Dec. 2022 (33.31) to Dec. 2023 (162.22).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Oxygenta Pharmaceutical Days Sales Outstanding Historical Data

The historical data trend for Oxygenta Pharmaceutical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxygenta Pharmaceutical Days Sales Outstanding Chart

Oxygenta Pharmaceutical Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

8.84

12.49

7.13

9.61

69.12

Oxygenta Pharmaceutical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															33.31	113.25	135.06	113.52	162.22

Competitive Comparison of Oxygenta Pharmaceutical's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxygenta Pharmaceutical's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Oxygenta Pharmaceutical's Days Sales Outstanding falls into.

Oxygenta Pharmaceutical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Oxygenta Pharmaceutical's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (15.759	+	101.597)	/	2 )	/	309.875	*	365
=	58.678					/	309.875	*	365
=	69.12

Oxygenta Pharmaceutical's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (162.667	+	0)	/	1 )	/	91.499	*	365 / 4
=	162.667					/	91.499	*	365 / 4
=	162.22

Oxygenta Pharmaceutical (BOM:524636) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Oxygenta Pharmaceutical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxygenta Pharmaceutical (BOM:524636) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032

Website

http://oxygentapharma.com

Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines